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52 Joint effect of alpha-melanocyte stimulating hormone and
met-enkephalin on respiratory function in guinea-pigs
D. T-Drinkovic1, D. Tjesˇic-D1, N. Sˇtambuk2, P. Konjevoda2, J. Kelee`ic1,
A. Votava1. 1Dept. of Pediatrics, University Hospital Centre, Zagreb, Croatia;
2Rudjer Bosˇkovic Institute, Zagreb, Croatia
Backround: We reported previously that alpha-melanocyte stimulating hormone
(a-MSH) and met-enkephalin (MET), endogenous opioid peptides with cytokine
properties, reduce bronchoconstriciton provoked by histamine in a guinea-pig
model [1,2]. Here we describe the effect of (a-MSH + MET) mixture on changes
in pulmonary function induced by histamine.
Methods: Experimental animals were Hartley guinea-pigs of both sexes, 6 per
group. Total body pletismography (Kozett–Rosller’s method modiﬁed by Gjurisˇ)
was used to record changes in airway resistance. The protective effect of the
tested substances was deﬁned as percentage of histamine blockade (the reduction
of histamine-induced bronchoconstriction; each animal its own control). The three
tested doses of mixtures (a-MSH + MET) were: 0.01mg/kg + 1mg/kg and 0.1 +
1mg/kg and 1 + 10mg/kg. Data were compared by t-test.
Results: There was no effect on basal amplitude of respirations regardless the dose
applied. However, after histamine application a signiﬁcant blockade of bronchco-
constriction was observed with the middle and high dose mixture (p< 0.02 and
p< 0.001, resp.).
Conclusion: The results implicate that (a-MSH + MET) mixtures modulate his-
tamine effects in guinea-pig lungs in a dose-dependent way. When compared to
previous results [1,2], the (a-MSH + MET) mixtures were more effective than each
peptide applied separately, indicating that they have additive effects. Further studies
are needed to deﬁne the practical and therapeutical use of these observations and
the possible beneﬁts for CF patients.
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53 Azithromycin (AZM) decreases Glutathione-S-Transferase (GST) –
T1 expression and activity in CF airway epithelial cells
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2Department of Pathology, General Pathology Section, University of Verona School
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Lung damage in CF is caused by mucus accumulation, Pseudomonas aeruginosa
infection and chronic inﬂammation. Extracellular reduced glutathione (GSH) is a
scavenger of free radicals produced by neutrophils in inﬂamed tissues.
Glutathione transferases conjugate GSH to a wide range of substrates including
oxidants and are involved in the synthesis of leukotrienes. Anti-inﬂammatory
properties have been proposed as possible mechanisms for clinical beneﬁcial effects
reported in CF patients treated with the macrolide AZM.
The aim of this study is to investigate the regulation of the GST-T1 expression and
activity by AZM.
We found 40% and 20% statistically signiﬁcant decreases of GST-T1 mRNA levels
in the CF cell lines 2CFSMEo- and IB3−1, respectively, in the presence of AZM.
Similar effects were detected on GST enzymatic activity and GST-T1 protein
expression.
We found that non-CF C38 cells express lower amounts of GST-T1 mRNA and
protein than CF isogenic IB3−1 cells. In the presence of AZM GST-T1 mRNA
and protein expression in CF cells were reduced to levels very similar to those of
isogenic non-CF cells.
Down-regulation of GST-T1 may result in increased availability of intracellular
GSH, making CF cells less susceptible to oxidative stress. Inhibition of GST-T1
might provide a therapeutic approach for limiting the effects of inﬂammation critical
for lung damage in CF patients.
Supported by: The Italian Cystic Fibrosis Research Foundation (grants
FFC10/05−17/06) and Associazione Veneta Lotta Contro la Fibrosi Cistica (Comi-
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54 Visualization of human sinus ventilation by radioactive Krypton
using the PARI Sinus pulsating system
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Objectives: To visualize the effect of the PARI SINUS pulsating drug delivery
system on ventilation of the human paranasal sinuses in healthy volunteers.
Methods: 81mKr-gas was continuously ventilated through the nasal tract of healthy
non-smokers in front of a single-head gamma camera (DIACAM, Siemens, Ger-
many), using the PARI SINUS™ pulsating drug delivery system. The nebulizer was
coupled to the right nostril and the left nostril was coupled via a ﬂow resistor to an
output tube. During ventilation with the Kr-gas (about 10−15 sec) the patient closes
his soft palate in order to transmit the pulsation and to prevent penetration into the
lower respiratory tract. The gas supply of the PARI SINUS was directly taken
from the 81mKr-gas generator output channel. The head of the gamma camera
was equipped with a medium-energy collimator. Kr-gas ventilation imaging was
performed with and without pulsation. Serial images were recorded with anterior
and lateral views. Additionally, MRI (magnetic resonance imaging) lateral slices of
the subjects’ head were recorded. The gamma camera images were superimposed
to the MRI images by adjusting the spatial resolution.
Results: Without pulsation only the nasal tract is ventilated and no sinus cavity can
be identiﬁed on the gamma camera images. When pulsation is added the sinuses
become ventilated and the maxillary sinuses can be identiﬁed in the gamma camera
images.
Conclusions: Gas penetration and distribution to the paranasal sinuses can be
obtained using the pulsating action of the PARI SINUS drug delivery system.
Without pulsation no ventilation is evident. Sinus ventilation enables drug delivery
via aerosols.
55* Treatment of CF sinonasal disease using a combination of
surgical procedure and coblation, a new therapeutic approach
H. Faict1,2, N. Curcio1,2, R. Haneuse1,2, C. El Hachem1,2, M.V. Guillot1,2,
M. Ellafﬁ2,1, M. Laurans2,1, J.F. Duhamel2,1. 1Lisieux CF Center, CHG R.
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Management of CF sinusitis is a growing challenging problem with longer life
expectancy; we report a new local therapeutic approach of CF associated polyposis
and turbinal hypertrophy using endoscopic probes delivering to turbinal mucosa
bipolar 10 watt low frequency energy current (coblation).
Patients and Methods: 12 patients (6 males, 6 females) ranging 5 to 26 years
from Lisieux and Caen CF centres underwent a two years prospective observational
cohort study. Before treatment: endoscopy, rhinomanometry, CT scan. According
to lesions: coblation therapy alone or coblation therapy + surgery (polypectomy
+ meatotomy). After treatment: endoscopic check up + rhinomanometry (8 weeks,
6 months, one year and every year); CT scan at 2 yearts of follow-up. Questionnaire
about sinusitis associated symptoms (headache, anosmia, rinorrhea; insomnia,
nocturnal snoring) before and after treatment were given to patients.
Results: in all patients, initial lesions were polyps + turbinal hypertrophy and
sinusitis. 10 underwent the same day polypectomy, meatotomy + coblation, 2 had
coblation only.
All patients were improved with no relapse of polyps, persisting turbinal retraction,
efﬁcient endonasal ﬂux, disappearance of anosmia, well being, diminution of overall
AB use. CT scans underwent a separate analysis.
Conclusion: the reported therapeutic approach seems to bring a relevant contribu-
tion in CF sinusitis treatment with a two years follow up.
